Advertisement
News
Subscribe to MDT Magazine News

PQA Recognizes Kaiser Permanente Hawaii for Excellence in Medication Safety

June 2, 2011 9:35 am | by Bio-Medicine.Org | Comments

HONOLULU, June 2, 2011 /- Kaiser Permanente Hawaii has received the inaugural Pharmacy Quality Alliance (PQA) Quality Award.  This award recognizes Kaiser Permanente's achievement of a 5-star rating on the PQA measures of medication safety that are included in the Centers for...

TOPICS:

Benchmark Electronics Recognized as Supplier for 2011 Design Medical Excellence Award Winner in the Radiological and Electromechanical Devices Category

June 2, 2011 9:34 am | by Bio-Medicine.Org | Comments

ANGLETON, Texas, June 2, 2011 /- Benchmark Electronics, Inc. (NYSE: BHE ), a leading integrated contract manufacturing provider, announced today that a product it helped commercialize and currently manufactures has won a 2011 Medical Design Excellence Awards. The Avedro Vedera KXS Vision...

TOPICS:

FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer

June 2, 2011 9:33 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., June 2, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today announced that a group of medications used to control high blood pressure, called angiotensin receptor blockers (ARBs), do not increase the risk of developing cancer in patients using...

TOPICS:
Advertisement

Mylan Receives Approval for Generic Version of Effexor XR® Capsules

June 2, 2011 9:32 am | by Bio-Medicine.Org | Comments

PITTSBURGH, June 2, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Venlafaxine Hydrochloride (HCl)...

TOPICS:

Commencement of GMP Production Project for Lead Anti-Cancer Product PAT-LM1

June 2, 2011 9:32 am | by Bio-Medicine.Org | Comments

MELBOURNE, Australia and PRINCETON, N.J., June 2, 2011 /- Patrys Limited (ASX: PAB) (the "Company"), a biopharmaceutical company focused on the development of novel treatments for cancer, is pleased to announce it has extended its relationship with Laureate Biopharmaceutical Services,...

TOPICS:

MedInformatix RIS Enhances Lenox Hill Radiology's Practice Management Efficiencies for Better Workflow and Improved Customer Service

June 2, 2011 8:32 am | by Bio-Medicine.Org | Comments

NEW YORK, June 2, 2011 /- Lenox Hill Radiology is first in its field with respect to leveraging cutting-edge technology to provide a full scope of diagnostic radiology services and care to patients, as well as to New York-area physicians, healthcare practitioners, hospitals, universities...

TOPICS:

Vanda Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference

June 2, 2011 7:33 am | by Bio-Medicine.Org | Comments

ROCKVILLE, Md., June 2, 2011 /- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced that Mihael H. Polymeropoulos, M.D., Vanda President and CEO...

TOPICS:

IDEV Technologies Announces Completion of SUPERB Clinical Trial Enrollment

June 2, 2011 6:35 am | by Bio-Medicine.Org | Comments

WEBSTER, Texas, June 2, 2011 /- IDEV Technologies, Inc. (IDEV) today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA® stent system for treatment of peripheral artery disease in the superficial femoral artery...

TOPICS:
Advertisement

Goodwin Biotechnology Announces a Collaboration With Alethia Biotherapeutics

June 2, 2011 6:35 am | by Bio-Medicine.Org | Comments

PLANTATION, Fla. and MONTREAL, June 2, 2011 /- Goodwin Biotechnology, Inc. (GBI), a full service CMO focused on process development and GMP manufacturing of cell culture derived biopharmaceuticals, and Alethia Biotherapeutics, Inc., a biotechnology company focused on monoclonal antibody...

TOPICS:

At SIIM 2011 Siemens Showcases Imaging IT Solutions for Driving Greater Value in Radiology and Other Specialties

June 2, 2011 6:34 am | by Bio-Medicine.Org | Comments

WASHINGTON, June 2, 2011 /- Siemens Healthcare (NYSE: SI) will showcase its portfolio of imaging information technology (IT) and workflow management solutions at the Society for Imaging Informatics in Medicine (SIIM) 2011 Annual Meeting from June 2-5, 2011, (booth 825) in the Gaylord...

TOPICS:

Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase

June 2, 2011 6:32 am | by Bio-Medicine.Org | Comments

NEW YORK, June 2, 2011 /- Citeline, the world's leading research authority on pharmaceutical clinical trials and intelligence recently completed a comprehensive review of clinical trial starts in the oncology therapeutic area to uncover trends and patterns in drug development. Over the...

TOPICS:

Benchmark Electronics Recognized as Supplier for 2011 Design Medical Excellence Award Winner

June 2, 2011 6:32 am | by Bio-Medicine.Org | Comments

ANGLETON, Texas, June 2, 2011 /- Benchmark Electronics, Inc. (NYSE: BHE ), a leading integrated contract manufacturing provider, announced today that a product it helped commercialize and currently manufactures has won the 2011 Medical Design Excellence Award and 2011 Edison Award for...

TOPICS:

Analyst upgrades Affymetrix on incoming CEO

June 2, 2011 5:45 am | by The Associated Press | Comments

An analyst upgraded shares of genetic test maker Affymetrix Inc. Thursday after the company appointed a new chief executive with significant experience in the life sciences industry.Baird analyst Quintin Lai upgraded company shares to "outperform" on expectations that incoming CEO Frank Witney...

Lumicell lands $2.7M in first funding round

June 2, 2011 5:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Lumicell Diagnostics Inc., a Waltham company that is developing a handheld device that can detect any cancer cells left behind after a cancer surgery, has raised $2.7 of a planned $3.9 million financing round, according to federal documents.

Hologic buys Chinese distributor TCT International for $135M

June 2, 2011 5:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Hologic Inc., a Bedford medical imaging and diagnostics product developer focused on women's health, has paid $135 million cash to acquire TCT International Co. Ltd., a medical products distributor in Beijing, China.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading